Engineers Gate Manager LP Surface Oncology, Inc. Transaction History

Engineers Gate Manager LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.65 - $5.08 $101,495 - $194,564	-38,300 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.73 - $7.9 $181,159 - $302,570	38,300 New	38,300 $183,000
Q3 2021 Nov 15, 2021	SELL	$5.16 - $7.98 $104,748 - $161,994	-20,300 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.45 - $9.09 $130,935 - $184,527	20,300 New	20,300 $151,000
Q4 2020 Feb 16, 2021	SELL	$6.87 - $10.48 $112,668 - $171,872	-16,400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$5.06 - $7.23 $82,984 - $118,572	16,400 New	16,400 $113,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.